Some drugs used to control high blood pressure and prevent heart failure were voluntarily recalled this past week due to an impurity that could possibly lead to cancer, the U.S. Food and Drug Administration said.
These products — with the active ingredient valsartan, a generic drug used to treat high blood pressure — may contain N-nitrosodimethylamine (NDMA), a possible human carcinogen. The FDA asked three companies, Major Pharmaceuticals, Solco Healthcare and Teva Pharmaceuticals Industries Ltd., to recall their valsartan products. Solco and Teva were also asked to recall their drugs containing valsartan/hydrochlorothiazide (HCTZ).
A 20-year-old college student who got a kidney donated by his identical twin brother is reaping a rare benefit — the ability to stop taking immunosuppressant drugs that most organ recipients take for the rest of their lives.
Brian Connor had been dealing with kidney disease and steadily declining kidney function since birth. Two years ago, his kidneys were so bad that he was put on dialysis three times a week for three to four hours at a time, he said. To save his life, his doctors said he’d need a transplant.
Fortunately, Connor was able to turn to his twin brother, Andrew, for help. The pair are identical twins, but issues in the development in utero left Brian with impaired kidneys and “a little bit smaller” than his brother, Brian said.